Globus Medical director plans $2.24M stock sale

Director James Robert Tobin Jr has filed a Rule 144 notice to sell 30,000 Globus Medical common shares via a cashless option exercise.

Rhea-AI Filing Summary

Globus Medical Inc (GMED) is the issuer for a planned sale of restricted securities disclosed under Rule 144 for the account of director James Robert Tobin Jr. The notice covers a proposed sale of 30,000 shares of Common Stock through Raymond James & Associates, Inc. on September 15, 2026 on the NYSE.

The filing describes the planned disposition as a cashless option exercise with the issuer listed as the party involved in the option exercise. The aggregate dollar amount associated with the 30,000 shares is stated as $2,236,000.

Key Figures

Shares proposed for sale: 30,000 shares Aggregate dollar amount: $2,236,000 Planned sale date: September 15, 2026 +2 more

5 metrics

Shares proposed for sale 30,000 shares Common Stock to be sold for the account of James Robert Tobin Jr under Rule 144

Aggregate dollar amount $2,236,000 Aggregate amount associated with 30,000 shares of Globus Medical common stock

Planned sale date September 15, 2026 Date associated with the proposed Rule 144 sale and cashless option exercise

Security type Common Stock Class of Globus Medical securities covered by the Form 144 notice

Trading market NYSE Exchange listed for the sale of the 30,000 shares of Common Stock

Key Terms

Rule 144, cashless option exercise, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

cashless option exercise financial

"Common | 09/15/2026 | Cashless Option Exercise | issuer"

attorney-in-fact regulatory

"as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Globus Medical (GMED)?

The Form 144 discloses a planned sale of 30,000 shares of Globus Medical common stock for the account of director James Robert Tobin Jr, to be executed through Raymond James & Associates, Inc. under a cashless option exercise.

How many Globus Medical (GMED) shares are proposed to be sold in this Form 144?

The notice covers a proposed sale of 30,000 shares of Globus Medical common stock. These shares are to be disposed of pursuant to a cashless option exercise reported in the filing.

What is the aggregate value of the Globus Medical (GMED) shares in the Form 144?

The filing states an aggregate dollar amount of $2,236,000 associated with the 30,000 shares of Globus Medical common stock covered by the planned Rule 144 sale.

Who is the person for whose account the GMED securities are to be sold?

The securities are to be sold for the account of James Robert Tobin Jr, identified as a director of Globus Medical Inc. The signature is provided by a representative of Raymond James & Associates, Inc. as attorney-in-fact.

Which broker is named in the Globus Medical (GMED) Form 144 filing?

The broker named is Raymond James & Associates, Inc., listed in connection with the 30,000 shares of Globus Medical common stock proposed for sale and the cashless option exercise.

On what date is the sale of Globus Medical (GMED) shares expected under this Form 144?

The filing lists September 15, 2026 as the date associated with the planned sale of the 30,000 shares of Globus Medical common stock on the NYSE via a cashless option exercise.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 02:30 PM Accepted by SEC EDGAR 09/15/2026 - 02:28 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001190128
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GLOBUS MEDICAL INC
SEC File Number	001-35621
Address of Issuer	2560 GENERAL ARMISTEAD AVENUE AUDUBON PENNSYLVANIA 19403
Phone	610-930-1800
Name of Person for Whose Account the Securities are To Be Sold	TOBIN JAMES R
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates Inc. 880 Carillon Parkway St. Petersburg FL 33716	30000	2236000.00	134261914	09/15/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2026	Cashless Option Exercise	issuer			30000	09/15/2026	Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Rashida Mitchell, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for James Robert Tobin Jr
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)